Globus Medical Inc. (NYSE: GMED) is one of the most undervalued stocks to buy and hold for 3 years. On July 22, Canaccord ...

Globus Medical Inc. (NYSE:GMED) is one of the best mid cap pharma stocks to buy. On July 15, Globus Medical announced the ...

Future Outlook Looking ahead, Globus Medical reaffirmed its prior promising guidance for 2025, projecting between $2.66 billion to $2.69 billion in revenue.

Globus Medical reported a 6.6% sales increase for Q4 2024 compared to the same period in 2023, with sales reaching approximately $657.0 million.

Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s full-year revenue guidance of $2.85 ...

Globus Medical will announce Q1 2025 financial results on May 8, followed by a teleconference. Quiver AI Summary Globus Medical, Inc. announced that it will release its financial results for the ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out why GMED stock is a Hold.

Medical technologies specialist Globus Medical(GMED -2.39%) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20.

Analysts have recently evaluated Globus Medical and provided 12-month price targets. The average target is $73.25, accompanied by a high estimate of $80.00 and a low estimate of $68.00. A 14.58% ...